Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

27.55 -0.49 (-1.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
From Simulations Plus, Inc.
Via Business Wire
Goldman Sachs Boosts Price Target On JinkoSolar Following Q2 Earnings, Also Check Out Other Major PT Changes Here
Oppenheimer raised the price target on S&P Global Inc. (NYSE: SPGI) from $404 to $419. Oppenheimer analyst Owen Lau maintained an Outperform rating on the stock. S&P Global shares fell 1% to $360.46 in... 
Via Benzinga
Veeva Systems Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
Veeva Systems stock reached a key technical milestone, with its Relative Strength Rating, rising to 81 on Tuesday, up from 66 the day before. 
Via Investor's Business Daily
Can Simulations Plus Stock Maintain Its Impressive Growth?
Simulations Plus, Inc. held up well in the company’s recently released financial results. 
Via Talk Markets
Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)
From Simulations Plus, Inc.
Via Business Wire
Evolent Health Is In Buy Zone Ahead Of Earnings Announcement
Medical cost management firm Evolent Health reports late Tuesday. 
Via Investor's Business Daily
Simulations Plus Presented New Scientific Developments at PAGE 2022
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
From Simulations Plus
Via Business Wire
Simulations Plus Realizes Early Success with its Concierge Program
From Simulations Plus, Inc
Via Business Wire
Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Stock Scores Composite Rating Move Up To 96
The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating. 
Via Investor's Business Daily
Earnings Scheduled For July 6, 2022
Companies Reporting After The Bell • Saratoga Investment (NYSE:SAR) is expected to report quarterly earnings at $0.53 per share on revenue of $19.21 million. 
Via Benzinga
Kornit Digital, Simulations Plus And 3 Stocks To Watch Heading Into Wednesday
With the US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Preview: Simulations Plus's Earnings
Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-07-06. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
From Simulations Plus, Inc.
Via Business Wire
Jim Cramer Recommends This Mining Company And 5 Other Stocks
On CNBC’s "Mad Money Lightning Round," Jim Cramer said AT&T Inc (NYSE: T) is a "distinct hold. If it were $18, it’s a buy. If it was $23, it’s a sell." 
Via Benzinga
Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
From Simulations Plus, Inc.
Via Business Wire
Privia Health Stock Among The Few That've Risen This Month
Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume. 
Via Investor's Business Daily
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
From Simulations Plus, Inc.
Via Business Wire
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Successfully Delivers FDA-Funded Project
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at the Berenberg Discover AI Seminar
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus: Q2 Earnings Insights
  Simulations Plus (NASDAQ:SLP) reported its Q2 earnings results on Wednesday, April 6, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Earnings Preview For Simulations Plus
Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-04-06. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
From Simulations Plus, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback